Basic Information
| LncRNA/CircRNA Name | LINC00628 |
| Synonyms | NA |
| Region | GRCh38_1:204368431-204369719 |
| Ensemble | ENSG00000280924 |
| Refseq | NR_027022 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | lung adenocarcinoma |
| ICD-0-3 | C34 |
| Methods | qPCR, Luciferase reporter assay, Western blot, RIP |
| Sample | cancerous tissues,cell lines (A549, H1650, HCC827, H1975) |
| Expression Pattern | up-regulated |
| Function Description | In this study, to identify cancer-related lncRNAs and genes, we screened for those lncRNAs that were differentially expressed in lung adenocarcinoma, which revealed LINC00628 overexpression and low expression of laminin subunit alpha 3 (LAMA3). |
| Pubmed ID | 31557618 |
| Year | 2019 |
| Title | Long Non-coding RNA LINC00628 Interacts Epigenetically with the LAMA3 Promoter and Contributes to Lung Adenocarcinoma. |
External Links
| Links for LINC00628 | GenBank HGNC NONCODE |
| Links for lung adenocarcinoma | OMIM COSMIC |